Skip to main content

Table 1 League table of each treatment regimen on total efficacy rate

From: Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis

Acotiamide

1.63 (0.89, 3.02)

1.15 (0.80, 1.64)

0.95 (0.68, 1.31)

2.63 (1.33, 5.36)

0.75 (0.50, 1.11)

0.46 (0.37, 0.58)

0.61 (0.33, 1.13)

Cinitapride

0.70 (0.42, 1.18)

0.58 (0.33, 1.02)

1.62 (0.75, 3.53)

0.46 (0.24, 0.87)

0.28 (0.16, 0.50)

0.87 (0.61, 1.25)

1.42 (0.85, 2.40)

Domperidone

0.83 (0.64, 1.06)

2.29 (1.16, 4.63)

0.65 (0.44, 0.97)

0.40 (0.30, 0.54)

1.06 (0.76, 1.46)

1.72 (0.98, 3.03)

1.21 (0.94, 1.55)

Itopride

2.77 (1.41, 5.59)

0.79 (0.53, 1.15)

0.49 (0.39, 0.62)

0.38 (0.19, 0.75)

0.62 (0.28, 1.34)

0.44 (0.22, 0.86)

0.36 (0.18, 0.71)

Metoclopramide

0.28 (0.13, 0.59)

0.18 (0.09, 0.34)

1.34 (0.90, 1.99)

2.18 (1.16, 4.14)

1.54 (1.04, 2.29)

1.27 (0.87, 1.88)

3.53 (1.70, 7.47)

Mosapride

0.62 (0.44, 0.87)

2.16 (1.72, 2.71)

3.52 (2.01, 6.24)

2.47 (1.87, 3.29)

2.05 (1.61, 2.06)

5.68 (2.98, 11.1)

1.61 (1.15, 2.27)

Placebo

  1. Notes: Odds ratio with 95% credible interval is described in each column. The odds ratio means prokinetic agent in the top left column comparing with prokinetic agent in the lower right column. Statistical validity is guaranteed when the 95% credible interval does not include 1, which is highlighted in bold